Affiliations 

  • 1 Saw Swee Hock School of Public Health, National University of Singapore, Singapore
  • 2 Health Intervention and Technology Assessment Program, Mueang Nonthaburi, Thailand
  • 3 Research Center for Health Policy and Economics, Hitotsubashi University, Kunitachi, Japan
BMJ Open Sport Exerc Med, 2020;6(1):e000909.
PMID: 33324487 DOI: 10.1136/bmjsem-2020-000909

Abstract

BACKGROUND AND OBJECTIVE: Increasing rates of urbanisation have been accompanied by higher levels of sedentary behaviour (SB) and reduced physical activity (PA) worldwide. While physical inactivity has long been identified as a major risk factor for morbidity and mortality, increased concerns about the detrimental associations between SB and health has led to the development of many interventions aimed at reducing SB and/or promoting PA. Due to the prominence of sedentary time spent at work, the workplace has been identified as a key setting to implement such interventions. Building an evidence base of effective strategies to reduce SB and/or promote PA at work is needed to help reduce the health risks faced by many employees.

METHODS AND ANALYSIS: We aim to conduct a review of reviews (RoR) to identify, evaluate and synthesise all systematic reviews (SRs) of workplace interventions aimed at reducing SB and/or promoting PA among adults. Systematic searches for relevant SRs will be conducted in six databases: Cochrane Systematic Review Database, Cumulative Index to Nursing & Allied Health Literature through EBSCOhost, EMBASE, PubMed including MEDLINE, Scopus and Web of Science. Selection for final inclusion and data extraction will be performed by two independent reviewers. SRs will be included if they assessed interventions aimed at reducing SB or promoting PA in the workplace, and if they report on changes in the respective behavioural outcomes in the occupational domain.

DISCUSSION: This RoR will be valuable to policy-makers and employers who are looking for strategies to promote health at work. This will also allow potential research gaps to be identified, so that the design of future studies can be better informed.

TRIAL REGISTERATION: This study has been registered with the PROSPERO International Prospective Register of Systematic Reviews (registration number CRD42020171774).

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.